This case highlights the aggressive nature and poor prognosis of cutaneous angiosarcoma despite multimodality treatment.
Highlights the aggressive clinical course of cutaneous angiosarcoma despite multimodality treatment; leaves.
Cutaneous angiosarcoma is a rare and aggressive malignant tumor of vascular origin. Multimodality treatment including surgery, radiotherapy and chemotherapy should be used according to age and local spread. Prognosis is poor with a 5-year survival of 10-15%. We report the case of an angiosarcoma of the scalp and face treated with sequential contact radiotherapy and chemotherapy. After local response, the patient progressed in non-irradiated zone then had liver metastasis.
No takes yet. Share an insight, caveat, or question.
Jmour et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: